← back to search

Christoph Tinchon

LKH Hochsteiermark · AT
Area of research
Hematology · Oncology
Research interest
Research interests include Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, and Multiple Myeloma Research and Treatments.
h-index
15
citations
1,751
works
72
NIH funding
primary concept
Medicine
email

Recent publications

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology 2022cited by 433position: middledoi
Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
Journal of Clinical Oncology 2018cited by 51position: middledoi
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Annals of Oncology 2013cited by 103position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ian Chau · Royal Marsden NHS Foundation Trust1 papers (2018–2018)Bas Groot Koerkamp · Erasmus MC1 papers (2018–2018)Georgios Antonios Margonis · Memorial Sloan Kettering Cancer Center1 papers (2018–2018)Alessandro Paniccia · UPMC Hillman Cancer Center1 papers (2018–2018)Kyu‐pyo Kim · Ulsan College1 papers (2018–2018)Jill Lacy · Yale Cancer Center1 papers (2018–2018)Bassel F. El‐Rayes · University of Alabama at Birmingham1 papers (2018–2018)Quisette P. Janssen · Directorate-General for Interpretation1 papers (2018–2018)Peter J. Hosein · University of Miami1 papers (2018–2018)Andrew H. Ko · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2018–2018)Nigel B. Jamieson · Glasgow Royal Infirmary1 papers (2018–2018)Nathan Bahary · Allegheny Health Network1 papers (2018–2018)Marjolein Y.V. Homs · Erasmus MC1 papers (2018–2018) · 1 papers (2018–2018)Mustafa Suker · Erasmus MC Cancer Institute1 papers (2018–2018)Casper H.J. van Eijck · University Medical Center1 papers (2018–2018)Stefan Buettner · Erasmus MC Cancer Institute1 papers (2018–2018)Matthew H. G. Katz · The University of Texas MD Anderson Cancer Center1 papers (2018–2018)Marc G. Besselink · Cancer Genomics Centre1 papers (2018–2018)